Editas Medicine, Inc. - Common Stock (EDIT)

CUSIP: 28106W103

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / Common Stock
Shares outstanding
82,773,190
Total 13F shares
23,494,260
Share change
+1,276,344
Total reported value
$381,310,290
Price per share
$16.23
Number of holders
84
Value change
+$21,340,854
Number of buys
38
Number of sells
27

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 28106W103?
CUSIP 28106W103 identifies EDIT - Editas Medicine, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of EDIT - Editas Medicine, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
6.6%
5,492,112
$74,035,000 30 Sep 2016
13F
Polaris Venture Management Co. VI, L.L.C.
13F
Company
5%
4,156,173
$56,025,000 30 Sep 2016
13F
Flagship Pioneering, LLC
13F
Company
4.2%
3,455,316
$46,578,000 30 Sep 2016
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
2.3%
1,874,396
$25,267,000 30 Sep 2016
13F
VIKING GLOBAL INVESTORS LP
13F
Company
2.1%
1,709,401
$23,043,000 30 Sep 2016
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
2.1%
1,709,400
$23,043,000 30 Sep 2016
13F
VANGUARD GROUP INC
13F
Company
1.5%
1,249,559
$16,844,000 30 Sep 2016
13F
Capital World Investors
13F
Company
0.36%
295,000
$3,977,000 30 Sep 2016
13F
MORGAN STANLEY
13F
Company
0.3%
252,351
$3,402,000 30 Sep 2016
13F
BlackRock Fund Advisors
13F
Company
0.21%
177,329
$2,390,000 30 Sep 2016
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
0.21%
170,739
$2,302,000 30 Sep 2016
13F
SABBY MANAGEMENT, LLC
13F
Company
0.16%
135,000
$1,820,000 30 Sep 2016
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.16%
128,400
$1,731,000 30 Sep 2016
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.12%
102,644
$1,383,000 30 Sep 2016
13F
STATE STREET CORP
13F
Company
0.12%
102,691
$1,382,000 30 Sep 2016
13F
NORTHERN TRUST CORP
13F
Company
0.11%
88,351
$1,191,000 30 Sep 2016
13F
Clarius Group, LLC
13F
Company
0.11%
87,231
$1,176,000 30 Sep 2016
13F
Casdin Capital, LLC
13F
Company
0.1%
85,470
$1,152,000 30 Sep 2016
13F
CREDIT SUISSE AG/
13F
Company
0.1%
85,332
$1,150,000 30 Sep 2016
13F
Omega Fund Management, LLC
13F
Company
0.08%
66,162
$892,000 30 Sep 2016
13F
DEUTSCHE BANK AG\
13F
Company
0.07%
60,342
$813,000 30 Sep 2016
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.07%
60,000
$809,000 30 Sep 2016
13F
STATE OF MICHIGAN RETIREMENT SYSTEM
13F
Company
0.06%
52,573
$709,000 30 Sep 2016
13F
Wildcat Capital Management, LLC
13F
Company
0.06%
46,775
$631,000 30 Sep 2016
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.05%
43,531
$586,000 30 Sep 2016
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.05%
40,000
$539,000 30 Sep 2016
13F
Bank of New York Mellon Corp
13F
Company
0.05%
38,551
$520,000 30 Sep 2016
13F
HARBOURVEST PARTNERS LLC
13F
Company
0.04%
36,362
$490,000 30 Sep 2016
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.04%
35,975
$485,000 30 Sep 2016
13F
TD ASSET MANAGEMENT INC
13F
Company
0.04%
30,970
$417,000 30 Sep 2016
13F
UBS Group AG
13F
Company
0.04%
30,468
$411,000 30 Sep 2016
13F
BlackRock Investment Management, LLC
13F
Company
0.03%
26,397
$356,000 30 Sep 2016
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.03%
24,200
$326,000 30 Sep 2016
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.03%
22,180
$299,000 30 Sep 2016
13F
BESSEMER GROUP INC
13F
Company
0.03%
21,818
$294,000 30 Sep 2016
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.03%
21,128
$285,000 30 Sep 2016
13F
HAMILTON LANE ADVISORS LLC
13F
Company
0.02%
19,323
$260,000 30 Sep 2016
13F
Emerald Acquisition Ltd.
13F
Company
0.02%
18,769
$253,000 30 Sep 2016
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.02%
14,600
$197,000 30 Sep 2016
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.02%
13,982
$189,000 30 Sep 2016
13F
ABERDEEN ASSET MANAGEMENT PLC/UK
13F
Company
0.02%
13,491
$182,000 30 Sep 2016
13F
TEACHERS ADVISORS, LLC
13F
Company
0.01%
10,948
$148,000 30 Sep 2016
13F
ELLINGTON MANAGEMENT GROUP LLC
13F
Company
0.01%
10,757
$145,000 30 Sep 2016
13F
PARK CIRCLE Co
13F
Company
0.01%
10,000
$135,000 30 Sep 2016
13F
Swiss National Bank
13F
Company
0.01%
9,900
$133,000 30 Sep 2016
13F
BLACKROCK ADVISORS LLC
13F
Company
0.01%
9,817
$132,000 30 Sep 2016
13F
GROUP ONE TRADING LLC
13F
Company
0.01%
8,721
$118,000 30 Sep 2016
13F
BlackRock Group LTD
13F
Company
0.01%
8,677
$117,000 30 Sep 2016
13F
SIMPLEX TRADING, LLC
13F
Company
0.01%
8,586
$115,000 30 Sep 2016
13F
HERSHEY TRUST CO
13F
Company
0.01%
7,273
$98,000 30 Sep 2016
13F

Institutional Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q4 2016

As of 31 Dec 2016, Editas Medicine, Inc. - Common Stock (EDIT) was held by 84 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,494,260 shares. The largest 10 holders included FMR LLC, Polaris Venture Management Co. VI, L.L.C., Flagship Pioneering Inc., Viking Global Investors LP, DEERFIELD MANAGEMENT CO, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BlackRock Fund Advisors, EcoR1 Capital, LLC, and Capital World Investors. This page lists 84 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2016 vs Q3 2016 Across Filers

Q3 2016 holders
71
Q4 2016 holders
84
Holder diff
13
Investor Q3 2016 Shares Q4 2016 Shares Share Diff Share Chg % Q3 2016 Value $ Q4 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.